DZ2515A1 - Dérivés de macrolides substitués en position c-4. - Google Patents

Dérivés de macrolides substitués en position c-4.

Info

Publication number
DZ2515A1
DZ2515A1 DZ980125A DZ980125A DZ2515A1 DZ 2515 A1 DZ2515 A1 DZ 2515A1 DZ 980125 A DZ980125 A DZ 980125A DZ 980125 A DZ980125 A DZ 980125A DZ 2515 A1 DZ2515 A1 DZ 2515A1
Authority
DZ
Algeria
Prior art keywords
derivatives substituted
macrolide derivatives
macrolide
substituted
derivatives
Prior art date
Application number
DZ980125A
Other languages
English (en)
Inventor
Brian Scott Bronk
Takushi Kaneko
Michael Anthony Letavic
Hengmiao Cheng
Edward Alan Glazer
Beingwei Vera Yang
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2515A1 publication Critical patent/DZ2515A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DZ980125A 1997-06-11 1998-06-10 Dérivés de macrolides substitués en position c-4. DZ2515A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
DZ2515A1 true DZ2515A1 (fr) 2003-02-01

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980125A DZ2515A1 (fr) 1997-06-11 1998-06-10 Dérivés de macrolides substitués en position c-4.

Country Status (40)

Country Link
EP (1) EP0988309B1 (fr)
JP (1) JP3262806B2 (fr)
KR (1) KR100369959B1 (fr)
CN (1) CN1145636C (fr)
AP (1) AP1189A (fr)
AR (1) AR013085A1 (fr)
AT (1) ATE310742T1 (fr)
AU (1) AU745006C (fr)
BG (1) BG64357B1 (fr)
BR (1) BR9810097A (fr)
CA (1) CA2293397C (fr)
CO (1) CO4950584A1 (fr)
DE (1) DE69832486T2 (fr)
DZ (1) DZ2515A1 (fr)
EA (1) EA002440B1 (fr)
ES (1) ES2251081T3 (fr)
GT (1) GT199800075A (fr)
HK (1) HK1025974A1 (fr)
HN (1) HN1998000074A (fr)
HR (1) HRP980315A2 (fr)
HU (1) HUP0004076A3 (fr)
ID (1) ID24530A (fr)
IL (1) IL132808A (fr)
IS (1) IS1979B (fr)
MA (1) MA24563A1 (fr)
MY (1) MY133027A (fr)
NO (1) NO315560B1 (fr)
NZ (1) NZ500652A (fr)
OA (1) OA11226A (fr)
PA (1) PA8452001A1 (fr)
PE (1) PE79999A1 (fr)
PL (1) PL337497A1 (fr)
SK (1) SK168299A3 (fr)
TN (1) TNSN98084A1 (fr)
TW (2) TWI224106B (fr)
UA (1) UA70298C2 (fr)
UY (1) UY25041A1 (fr)
WO (1) WO1998056801A1 (fr)
YU (1) YU62999A (fr)
ZA (1) ZA985016B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012552A1 (fr) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES UTILISES COMME AGENTS ANTIMICROBIENS VETERINAIRES
EP1779853A3 (fr) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides en tant qu'agents anti-microbiens à usage vétérinaire
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
JP4043191B2 (ja) 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
CA2292359C (fr) * 1999-01-28 2004-09-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
BR0009101A (pt) * 1999-08-24 2002-02-05 Abbott Lab 9a-azalidas com atividade antibacteriana
DE60003586T2 (de) * 2000-01-27 2004-01-08 Pfizer Products Inc., Groton Antibiotische azalid-zusammensetzungen
MXPA03009786A (es) * 2001-04-27 2004-01-29 Pfizer Prod Inc Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-sustituidos.
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
RS20050007A (en) * 2002-07-08 2007-09-21 Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., Novel nonsteroidal anti- inflammatory substances, compositions and methods for their use
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 4員環構造を有する10a−アザライド化合物
ES2565083T3 (es) 2008-10-24 2016-03-31 Cempra Pharmaceuticals, Inc. Biodefensas usando macrólidos que contienen triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2012038372A1 (fr) * 2010-09-20 2012-03-29 Novartis Ag Nouveau procédé de préparation de 9-déoxo-9a-aza-9a-homoérythromycine a modifiée dans le c-4'' du cycle cladinose par un groupe époxyde
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
EP3273969A4 (fr) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
GR80277B (en) * 1983-09-06 1985-01-04 Pfizer Azahomoerythromycin b derivatives and intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (fr) * 1991-04-04 1998-08-04 James V. Heck Derives de 9-desoxo-8a-aza-8a-homoerythromycine a modifies en positions 4"- et 8a
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
HN1998000074A (es) 1999-01-08
SK168299A3 (en) 2000-09-12
NO315560B1 (no) 2003-09-22
NZ500652A (en) 2001-10-26
UA70298A (uk) 2004-10-15
EP0988309B1 (fr) 2005-11-23
AU745006C (en) 2006-02-23
CN1259955A (zh) 2000-07-12
HK1025974A1 (en) 2000-12-01
UY25041A1 (es) 2000-09-29
DE69832486T2 (de) 2006-07-27
WO1998056801A1 (fr) 1998-12-17
ID24530A (id) 2000-07-20
OA11226A (en) 2003-07-16
PL337497A1 (en) 2000-08-28
NO996107D0 (no) 1999-12-10
JP2000514097A (ja) 2000-10-24
CN1145636C (zh) 2004-04-14
BR9810097A (pt) 2000-08-08
YU62999A (sh) 2002-10-18
HUP0004076A3 (en) 2003-05-28
MA24563A1 (fr) 1998-12-31
BG103969A (en) 2000-07-31
MY133027A (en) 2007-10-31
IL132808A (en) 2004-08-31
AU745006B2 (en) 2002-03-07
IL132808A0 (en) 2001-03-19
GT199800075A (es) 1999-11-30
AR013085A1 (es) 2000-12-13
UA70298C2 (uk) 2004-10-15
KR100369959B1 (ko) 2003-02-12
CA2293397C (fr) 2004-08-31
IS5250A (is) 1999-11-16
AP1189A (en) 2003-07-16
PA8452001A1 (es) 2000-05-24
TNSN98084A1 (fr) 2005-03-15
PE79999A1 (es) 1999-08-25
IS1979B (is) 2005-01-14
TWI224106B (en) 2004-11-21
AP9801254A0 (en) 1998-06-30
BG64357B1 (bg) 2004-11-30
CA2293397A1 (fr) 1998-12-17
JP3262806B2 (ja) 2002-03-04
ES2251081T3 (es) 2006-04-16
DE69832486D1 (de) 2005-12-29
EA199901014A1 (ru) 2000-06-26
EA002440B1 (ru) 2002-04-25
ZA985016B (en) 1999-12-10
EP0988309A1 (fr) 2000-03-29
CO4950584A1 (es) 2000-09-01
HRP980315A2 (en) 1999-04-30
AU7228198A (en) 1998-12-30
HUP0004076A2 (hu) 2001-04-28
NO996107L (no) 2000-02-10
KR20010013633A (ko) 2001-02-26
ATE310742T1 (de) 2005-12-15
TW200418871A (en) 2004-10-01

Similar Documents

Publication Publication Date Title
DZ2515A1 (fr) Dérivés de macrolides substitués en position c-4.
IS5251A (is) 9-oxím erýþrómýsín afleiður
DZ3168A1 (fr) Dérivés de purine.
ATE377018T1 (de) Erythromycinderivate
PT901474E (pt) Derivados de aril-pirimidina.
DK0941998T3 (da) 3,6-ketalmakrolidantibiotika
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
DZ2698A1 (fr) Macrolides nouveaux.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
NO20014362L (no) Erytromycinderivater
DZ3036A1 (fr) Dérivés de monofluoroalkyles.
BR9916188B1 (pt) derivados de cromano.
TR199700354A3 (tr) Karbohidrat türevleri.
ZA983902B (en) Erythromycin derivatives.
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
DZ2696A1 (fr) Dérivés glucidiques.
ES1039780Y (es) Dispositivo retenedor de puertas.
ES1039978Y (es) Dispositivo de articulacion de puertas.
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives